2022 2022 Annual Meeting: Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Clinical Trials View PDF
2022 2022 Annual Meeting: Supporting a Patient-Centric Approach to Dose Optimization in Oncology: The Essential Role of Patient-Reported Outcomes (PROs) View PDF
2022 Circulating Tumor DNA in Development of Therapies for Cancer: An Evidentiary Roadmap to an Early Endpoint for Regulatory Decision-Making View PDF
2022 Multi-Cancer Early Detection Screening Tests: Considerations for Use of Real-World Data View PDF
2022 Expedited Development of Diagnostics for Therapies Targeting Rare Biomarkers or Indications View PDF
2021 2021 Annual Meeting: Assessing the Use of ctDNA as an Early Endpoint in Early-Stage Disease View PDF
